RG
RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
$0.00 +0.00% (+$0.00)
1M +57.14%
Market Cap $898.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.01x
P/E N/A
EV/EBITDA N/A
Growth
20 /100
Declining Rev. growth 0.00%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 2,249.84%
Op. margin 1,826.45%
Quality
61 /100
Average ROIC 1,654.75%
ROA 451.89%
Asset turnover 0.20x
Debt
52 /100
Moderate Current ratio 0.55x
Int. coverage -4.31x
Net debt/EBITDA -0.82x
Stability
31 /100
Unstable Beta 4.73x
Rev. volatility 0.00%
EPS volatility 4,091.19%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RGRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. J. Finkelstein
Employees
2
Headquarters
Rockville